Aligos therapeutics to announce first quarter results on may 4, 2023

South san francisco, calif., april 27, 2023 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs, “aligos”, the “company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it will report the company's first quarter 2023 financial results on thursday, may 4, 2023, after the close of the u.s. financial markets.
ALGS Ratings Summary
ALGS Quant Ranking